Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE was delisted on the 31st of July, 2024.
2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
99% less funds holding
Funds holding: 231 → 2 (-229)
100% less funds holding in top 10
Funds holding in top 10: 16 → 0 (-16)
100% less capital invested
Capital invested by funds: $6.42B → $20.7K (-$6.42B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 228
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$297 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Bain Capital Investors
Boston,
Massachusetts
|
-$2.69B |
| 2 |
PA
Perceptive Advisors
New York
|
-$441M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$308M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$293M |
| 5 |
BlackRock
New York
|
-$146M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GRP
226
Global Retirement Partners
San Rafael,
California
| – | -$491 | -12 | Closed |
|
227
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$372 | -9 | Closed |
|
|
GI
228
GAMMA Investing
Foster City,
California
| – | -$164 | -4 | Closed |
|
|
PA
229
Parallel Advisors
San Francisco,
California
| – | -$164 | -4 | Closed |
|
CERE Hedge Fund Activity: Q3 2024 in Review
2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.
Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.
- 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
- Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
- The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
- The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.
Based on aggregated 13F filings for Q3 2024.